- Founded in 1997, the Interstitial Lung Disease (ILD) Program is an internationally recognized center of excellence.
- An interdisciplinary team provides high-quality care through decades of combined experience.
- Doctors within the program collaborate on cases with physicians around the country.
Interstitial lung disease (ILD) refers to a group of diseases that irritate, inflame or scar the lungs and supporting air sacs. When this scarring (or pulmonary fibrosis) occurs, it can cause stiffness in the lungs, making it difficult for a person to breathe enough oxygen into the bloodstream.
Yale Medicine’s Interstitial Lung Disease Program focuses on bringing together specialists from different disciplines, including pulmonary pathologists, chest radiologists, rheumatologists and occupational medicine physicians, to provide patients with the best care.